findmyKOL
Clinical trialNCT03289299Active, not recruitingPhase 2Interventional

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

SponsorInternational Myeloma FoundationEnrollment87Smoldering Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

  • University of Chicago Medical Center

    Chicago, Illinois, United States

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana, United States

  • University of Kansas Cancer Center

    Westwood, Kansas, United States

  • University of Maryland Medical Center

    Baltimore, Maryland, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • Levine Cancer Institute

    Charlotte, North Carolina, United States

  • Swedish Cancer Institute

    Seattle, Washington, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carfilzomib →Daratumumab →Dexamethasone →Lenalidomide →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 May 2018
Primary completion
26 Sept 2023
Completion
15 Nov 2031
Last update posted
12 Dec 2023
Registered enrollment
87
Registry id
NCT03289299
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.